Buy Eli Lilly and Company Stocks - View LLY Live Price (2026)

LLY

TYPE Stocks

GROUP Stocks

BASE Eli Lilly an...

SECOND

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

Add to Watchlist

LLY Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

GO PREMIUM

TRADE NOW

GET READY

<% signal.analyst %>

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: Mar 16, 2026 04:10:19 PM (GMT)

LLY: The current market price is 981.96, representing a percentage change of +0.29%.

Support and Resistance Levels Current support levels are 991.24, 988.2, and 984.51, while resistance levels are 997.97, 1001.66, and 1004.7. The pivot point is 994.93.

Indicators RSI is at 42.02, indicating a neutral zone, while ATR is at 0.73788, suggesting low volatility. ADX is at 69.24, indicating a strong trend. The Parabolic SAR flipped, currently at 990.45524, indicating potential resistance. Both the 50-day SMA (990.564) and the 200-day EMA (986.8942) support the bearish trend.

Market Sentiment The market is bearish as the price is below the pivot point of 994.93, supported by RSI, ADX, and SMA indicators.

LLY Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>

Market Trend

Strong Sell

Sell

Neutral

Buy

Strong Buy

Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>

Strong Sell

Sell

Neutral

Buy

Strong Buy

Trend Indicators

NAME

VALUE

ACTION

Bollinger Bands

UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>

MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>

LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>

Sell

Buy

Parabolic SAR

<% indicators.data[indicators.interval.active].sar.value %>

Sell

Buy

Standard Deviation

<% indicators.data[indicators.interval.active].stddev.value %>

High Volatility

Low Volatility

Oscillators

NAME

VALUE

ACTION

RSI(14)

<% indicators.data[indicators.interval.active].rsi.value %>

Sell

Buy

MACD(12,26)

<% indicators.data[indicators.interval.active].macd.value %>

Buy

Sell

Neutral

ATR

<% indicators.data[indicators.interval.active].atr.value %>

High Volatility

Low Volatility

STOCH(9,6)

<% indicators.data[indicators.interval.active].stochastics.value %>

Buy

Sell

ADX

<% indicators.data[indicators.interval.active].adx.value %>

High Volatility

Low Volatility

Moving Averages

PERIOD

SIMPLE

EXPONENTIAL

MA5

<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell

MA10

<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell

MA20

<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell

MA50

<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell

MA100

<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT

CLASSIC

FIBONACCI

CAMARILLA

WOODIE

<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (lly) Eli Lilly and Company

Company Background

Eli Lilly and Company, publicly traded under the symbol LLY on the NYSE, is a global leader in the pharmaceutical industry. Founded in 1876 and headquartered in Indianapolis, Indiana, Eli Lilly focuses on the discovery, development, and manufacture of innovative medicines. The company has a rich heritage of pioneering scientific advancements and is renowned for its commitment to improving patients' lives through cutting-edge treatments in various therapeutic areas, including diabetes, oncology, immunology, and neuroscience.

Market Position

As one of the top pharmaceutical companies worldwide, Eli Lilly holds a strong market position driven by a diverse portfolio of products and a robust pipeline of new therapies. The company has established itself as a key player in the diabetes care market with its blockbuster medication, Trulicity, which has significantly contributed to its revenue streams. Additionally, Eli Lilly has made considerable strides in oncology with drugs such as Verzenio and Emgality, targeting specific patient populations and addressing unmet medical needs. Eli Lilly's strategic partnerships and collaborations further enhance its market presence and innovation capabilities.

Key Financial and Industry Highlights

In recent years, Eli Lilly has demonstrated impressive financial performance, with substantial growth in revenue fueled by the successful launch of new products and the expansion of existing therapies. The company reported a revenue increase of 20% year-over-year in its latest financial statements, showcasing strong demand for its innovative treatments. Furthermore, Eli Lilly has invested significantly in research and development, allocating approximately 25% of its revenue to R&D initiatives. This commitment to innovation has resulted in a rapidly expanding product pipeline, with several promising candidates in late-stage clinical trials. As the global pharmaceutical landscape continues to evolve, Eli Lilly is well-positioned to capitalize on emerging trends in personalized medicine and biotechnology, ensuring sustained growth and long-term shareholder value.

Check all LLY conversion rates

Related Stocks

PFE

Pfizer Inc.

Industry Drug Manufacturers - General

Exchange NYSE

JNJ

Johnson & Johnson

Industry Drug Manufacturers - General

Exchange NYSE

ABBV

AbbVie Inc.

Industry Drug Manufacturers - General

Exchange NYSE